2022³â ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ÃæûÁöȸ 12¿ù Áý´ãȸ : 2022-12-20±³À°ÀÏÀÚ : 2022-12-20
±³À°Àå¼Ò : ¹ÙÀÌ¿À´Ï¾Æ ±Û·Î¹ú¼¾ÅÍ ´ëÀü±¤¿ª½Ã À¯¼º±¸ °üÆòµ¿ 686
±³À°ÁÖÁ¦ :
2022³â ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ÃæûÁöȸ 12¿ù Áý´ãȸÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ÃæûÁöȸ
´ã´çÀÚ : ÀÌÀ¯Áø
¿¬¶ôó : 070-4436-3304
À̸ÞÀÏ :
kscp2@kams.or.kr ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 30¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
´ëÀü±¤¿ª½Ã±³À°½Ã°£ : 2 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-20 PART1 16:10~16:25 Clinical Laboratory Innovations During COVID-19 Pandemic Marrisa Orillaza(Department of Laboratory Medicine ACE Group of Hospitals)
±³À°½Ã°£ 12-20 PART1 16:25~16:40 Latest Situation of COVID-19 in Hong Kong Daniel Tam(CryolifeCompany Ltd)
±³À°½Ã°£ 12-20 PART1 16:40~16:55 Pandemic Preparedness and Response: A Singapore Experience Eddie Ang(Singapore Association for Medical Laboratory Sciences)
±³À°½Ã°£ 12-20 PART1 16:55~17:10 Laboratory Response for COVID-19 in Korea È«±âÈ£(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 12-20 PART1 17:10~17:25 The Impact of COVID on the Blood Safety Program Dorothy K. Byabazaire(Uganda Blood Transfusion Service Kampala)
±³À°½Ã°£ 12-20 PART1 17:25~17:40 Analyse the Factors Affecting the Decision of EQA Sample Selection Thai My Tran(Center for Standardization and Quality control in medical laboratory of HCMC, University of Economics Ho Chi Minh City)
±³À°½Ã°£ 12-20 PART2 18:15~18:30 Challenges of Blood Donor Screening in Korea ±èÇö¿Á(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 12-20 PART2 18:30~18:45 HIV, HBV, HCV Quantitative Measurement and Clinical Application ¹ÚÈñ¼ö(ÃæºÏ´ëÇб³º´¿ø)
±³À°½Ã°£ 12-20 PART2 18:45~19:00 Advances in Antiviral Therapy and Viral Load Monitoring ÀÌÇѾÆ(ÀÌ´ë¸ñµ¿º´¿ø)
±³À°½Ã°£ 12-20 PART2 19:00~19:15 Laboratory Operations for Viral Load Testing and Surveillance ¾çÁ¤¼®(°í´ë±¸·Îº´¿ø)